Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain

Chinese Medical Journal

Volumn 117, Issue 11, 2004, Pages 1625-1629

  Zhang, Chuan Hai ^a   Guo, Zhong Min ^b   Zheng, Huan Ying ^c   Lu, Jia Hai ^b   Wang, Yi Fei ^d   Yan, Xin Ge ^c   Zhao, Yong ^b   Du, Xiong Wei ^b   Zhang, Xin ^c   Fang, Ling ^c   Ling, Wen Hua ^b   Qi, Shu Yuan ^a   Yu, Xin Bing ^b   Zhong, Nan Shan ^e  

^a SOUTH CHINA INSTITUTE OF BOTANY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Ctr Disease Control and Prevention   (China)

^d JINAN UNIVERSITY   (China)

^e GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Coronavirus; Immunogenicity; Severe acute respiratory syndrome; Vaccines, inactivated

Indexed keywords

IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; RABBIT; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VERO CELL; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS; RABBITS; SARS VIRUS; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 10244266385     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Zhang CH, Wang YF, Zhang MY, et al. Recent progress in the studies on SARS and its pathogeny. Chin Bull Life Sci (Chin) 2003;15:129-133.
2. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-1976.
3. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319-1325.
4. Marra MA, Jones SJ, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003;300:1399-1404.
5. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-1399.
6. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302:276-278.
7. Rappuoli R, Miller HI, Falkow S, et al. The intangible value of vaccination. Science 2002;297:937-939.
8. Yan XG, Wan ZY, Zhang X, et al. Isolation and identification of SARS virus in Guangdong province. Chin J Exp Clin Virol (Chin) 2003;17:213-216.
9. Zhang X, Li H, Zheng K, et al. Isolation, identification and variance of a coronavirus from a imoutting SARS case. Chin J Microbiol Immunol (Chin) 2003;23:409-417.
10. Lu JH, Yan XG, Guo ZM, et al. Establishment of SARS virus vaccine line. Guangdong Med J (Chin) 2003;24 (SARS Suppl II):194-195.
11. Manual for the virological investigation of polio. Geneva: World Health Organization, 1997. (Accessed March, 1997 at http://www.who.ch/programmes/gpv/gEnglish/avail/gpvcatalog/catlogl.htm).
12. Zhu MS, Pan Y, Chen HQ, et al. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol Lett 2004;92:237-243.
13. Nass PH, Elkins KL, Weir JP. Protective immunity against herpes somplex virus generated by DNA vaccination compared to natural infection. Vaccine 2001;19:1538-1546.
14. Lu JH, Wang YF, Yu XB, et al. Preliminary study on inactivated SARS coronavirus vaccine. Guangdong Med J (Chin) 2003;24(SARS Suppl I):129-130.
15. Zhong NS, Zheng BJ, Li YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China in February 2003. Lancet 2003; 362:1353-1358.
16. Tang L, Wang J, Qin ED, et al. Preparation, characterization and preliminary in vivo studies of inactivated SARS-CoV vaccine. Chin Sci Bull 2003;48:2621-2625.
17. Li LJ, Wang ZG, Lu YY, et al. Severe acute respiratory syndrome-associated coronavirus genotype and its characterization. Chin Med J 2003;116:1288-1292.
18. Zhou T, Wang H, Luo D, et al. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies. J Virol 2004;78:7217-7226.
19. Zhao P, Ke JS, Qin ZL, et al. DNA vaccine of SARS-CoV S gene induces antibody response in mice. Acta Biochim Biophys Sin 2004;36:37-41.
20. Kim TW, Lee JH, Hung CF, et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 2004;78:4638-4645.
21. Ruan YJ, Wei CL, Ee LA, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003;361:1779-1787.
22. Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004;303:1666-1669.
23. Wang ZG, Li LJ, Luo Y, et al. Molecular biological analysis of genotyping and phylogeny of severe acute respiratory syndrome associated coronavirus. Chin Med J 2004;117:42-48.